Douglas J. Manion - 09 Mar 2023 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
ACRS
Transactions as of
09 Mar 2023
Net transactions value
+$50,278
Form type
4
Filing time
09 Mar 2023, 16:56:40 UTC
Previous filing
03 Feb 2023
Next filing
17 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Purchase $50,278 +6,500 $7.74 6,500 09 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.